Page 2506 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 152 Hematologic Manifestations of Childhood Illness 2237.e1

REFERENCES 26. Melendez E, Harper MB: Risk of serious bacterial infection in isolated
and unsuspected neutropenia. Acad Emerg Med 17:163, 2010.
1. Lascari AD: Hematologic manifestations of childhood diseases, New York, 27. Strausbaugh LJ: Hematologic manifestations of bacterial and fungal
1984, Thieme-Stratton. infections. Hematol Oncol Clin North Am 1(2):185–206, 1987.
2. Abshire TC: The anemia of inflammation: a common cause of child- 28. Lukens JN: Eosinophilia in children. Pediatr Clin North Am 19(4):969–
hood anemia. Pediatr Clin North Am 43(3):623–637, 1996. 981, 1972.
3. Jansson LT, Kling S, Dallman PR: Anemia in children with acute 29. Kilpi T, Anttila M, Kallio MJ, et al: Thrombocytosis and throm-
infections seen in a primary care pediatric outpatient clinic. Pediatr bocytopenia in childhood bacterial meningitis. Pediatr Infect Dis J
Infect Dis 5(4):424–427, 1986. 11(6):456–460, 1992.
4. Abshire TC, Reeves JD: Anemia of acute inflammation in children. 30. Dame C, Sutor AH: Primary and secondary thrombocytosis in child-
J Pediatr 103(6):868–871, 1983. hood. Br J Haematol 129(2):165–177, 2005.
5. Ballin A, Lotan A, Serour F, et al: Anemia of acute infection in hos- 31. Heath HW, Pearson HA: Thrombocytosis in pediatric outpatients.
pitalized children—no evidence of hemolysis. J Pediatr Hematol Oncol J Pediatr 114(5):805–807, 1989.
31(10):750–752, 2009. 32. Matsubara K, Fukaya T, Nigami H, et al: Age-dependent changes in
6. Buchanan GR: The mild anemia of acute infection. Pediatr Infect Dis the incidence and etiology of childhood thrombocytosis. Acta Haematol
4(3):225–228, 1985. 111(3):132–137, 2004.
7. Shurin SB, Anderson P, Zollinger J, et al: Pathophysiology of hemo- 33. Nathan DG, Orkin SH: Ginsburg D, Nathan DG, editors: Nation and
lysis in infections with Hemophilus influenzae type b. J Clin Invest Oski’s hematology of infancy and childhood, ed 6, Philadelphia, 2003,
77(4):1340–1348, 1986. Saunders, p 1620.
8. Berkowitz FE: Hemolysis and infection: categories and mechanisms of 34. Ware R, Kurtzberg J, Friedman HS, et al: Chronic immune-mediated
their interrelationship. Rev Infect Dis 13(6):1151–1162, 1991. thrombocytopenia after varicella infection. J Pediatr 112(5):742–744,
9. Pamuk GE, Dogan Celik A, Uyanik MS: Brucellosis triggering hemo- 1988.
lytic anemia in glucose-6-phosphate dehydrogenase deficiency. Med 35. DiMaggio D, Anderson A, Bussel JB: Cytomegalovirus can make
Princ Pract 18(4):329–331, 2009. immune thrombocytopenic purpura refractory. Br J Haematol
10. Seitz RC, Buschermohle G, Dubberke G, et al: The acute infection- 146(1):104–112, 2009.
associated hemolytic anemia of childhood: immunofluorescent detec- 36. Corrigan JJ, Jr: Thrombocytopenia: a laboratory sign of septicemia in
tion of microbial antigens altering the erythrocyte membrane. Ann infants and children. J Pediatr 85(2):219–221, 1974.
Hematol 67(4):191–196, 1993. 37. Francis RB, Jr: Acquired purpura fulminans. Semin Thromb Hemost
11. Cassimos D, Bezirgiannidou Z, Pantelidou D, et al: Warm auto- 16(4):310–325, 1990.
immune hemolytic anemia following recurrent mycoplasma pneumonia 38. Manco-Johnson MJ, Nuss R, Key N, et al: Lupus anticoagulant and
infections in a child with Down syndrome. Pediatr Hematol Oncol protein S deficiency in children with postvaricella purpura fulminans
25(7):693–698, 2008. or thrombosis. J Pediatr 128(3):319–323, 1996.
12. Chambers LA, Rauck AM: Acute transient hemolytic anemia with a 39. Boccara O, Lesage F, Regnault V, et al: Nonbacterial purpura fulminans
positive Donath-Landsteiner test following parvovirus B19 infection. and severe autoimmune acquired protein S deficiency associated with
J Pediatr Hematol Oncol 18(2):178–181, 1996. human herpesvirus-6 active replication. Br J Dermatol 161(1):181–183,
13. Young N: Hematologic and hematopoietic consequences of B19 2009.
parvovirus infection. Semin Hematol 25(2):159–172, 1988. 40. Faust SN, Levin M, Harrison OB, et al: Dysfunction of endothelial
14. Anderson MJ, Higgins PG, Davis LR, et al: Experimental parvoviral protein C activation in severe meningococcal sepsis. N Engl J Med
infection in humans. J Infect Dis 152(2):257–265, 1985. 345(6):408–416, 2001.
15. Mustafa MM, McClain KL: Diverse hematologic effects of parvovirus 41. Fijnvandraat K, Derkx B, Peters M, et al: Coagulation activation and
B19 infection. Pediatr Clin North Am 43(3):809–821, 1996. tissue necrosis in meningococcal septic shock: severely reduced protein
16. Cauff BE, Quinn CT: Transient parvovirus-associated hypoplasia of C levels predict a high mortality. Thromb Haemost 73(1):15–20,
multiple peripheral blood cell lines in children with chronic hemolytic 1995.
anemia. Pediatr Blood Cancer 50(4):861–864, 2008. 42. Kondaveeti S, Hibberd ML, Booy R, et al: Effect of the factor V Leiden
17. Berry PJ, Gray ES, Porter HJ, et al: Parvovirus infection of the human mutation on the severity of meningococcal disease. Pediatr Infect Dis J
fetus and newborn. Semin Diagn Pathol 9(1):4–12, 1992. 18(10):893–896, 1999.
18. Rogers BB, Rogers ZR, Timmons CF: Polymerase chain reaction 43. Gurgey A, Aytac S, Kanra G, et al: Outcome in children with purpura
amplification of archival material for parvovirus B19 in children with fulminans: report on 16 patients. Am J Hematol 80(1):20–25, 2005.
transient erythroblastopenia of childhood. Pediatr Pathol Lab Med 44. Kuppermann N, Inkelis SH, Saladino R: The role of heparin in the
16(3):471–478, 1996. prevention of extremity and digit necrosis in meningococcal purpura
19. Todd JK: Childhood infections: diagnostic value of peripheral white fulminans. Pediatr Infect Dis J 13(10):867–873, 1994.
blood cell and differential cell counts. Am J Dis Child 127(6):810–816, 45. Hanada T, Abe T, Takita H: Antithrombin III concentrates for treat-
1974. ment of disseminated intravascular coagulation in children. Am J
20. Lembo RM, Rubin DH, Krowchuk DP, et al: Peripheral white blood Pediatr Hematol Oncol 7(1):3–8, 1985.
cell counts and bacterial meningitis: implications regarding diagnostic 46. Kreuz WD, Schneider W, Nowak-Göttl U: Treatment of consumption
efficacy in febrile children. Pediatr Emerg Care 7(1):4–11, 1991. coagulopathy with antithrombin concentrate in children with acquired
21. McCarthy PL, Jekel JF, Dolan TF, Jr: Temperature greater than or equal antithrombin deficiency – a feasibility pilot study. Eur J Pediatr
to 40 C in children less than 24 months of age: a prospective study. 158(Suppl 3):S187–S191, 1999.
Pediatrics 59(5):663–668, 1977. 47. White B, Livingstone W, Murphy C, et al: An open-label study of
22. Shah SS, Shofer FS, Seidel JS, et al: Significance of extreme leukocytosis the role of adjuvant hemostatic support with protein C replacement
in the evaluation of febrile children. Pediatr Infect Dis J 24(7):627–630, therapy in purpura fulminans-associated meningococcemia. Blood
2005. 96(12):3719–3724, 2000.
23. Sadowitz PD, Oski FA: Differences in polymorphonuclear cell counts 48. Warren BL, Eid A, Singer P, et al: Caring for the critically ill patient:
between healthy white and black infants: response to meningitis. high-dose antithrombin III in severe sepsis: a randomized controlled
Pediatrics 72(3):405–407, 1983. trial. JAMA 286(15):1869–1878, 2001.
24. Baranski B, Young N: Hematologic consequences of viral infections. 49. de Kleijn ED, de Groot R, Hack CE, et al: Activation of protein
Hematol Oncol Clin North Am 1(2):167–183, 1987. C following infusion of protein C concentrate in children with
25. Alexandropoulou O, Kossiva L, Haliotis F, et al: Transient neutropenia severe meningococcal sepsis and purpura fulminans: a randomized,
in children with febrile illness and associated infectious agents: 2 years’ double-blinded, placebo-controlled, dose-finding study. Crit Care Med
follow-up. Eur J Pediatr 172(6):811–819, 2013. 31(6):1839–1847, 2003.